IL17A and breast carcinoma: The results showed that the target genes of the upmodulated DE-miRNAs were particularly associated with pathways in cancer, breast cancer, basal cell carcinoma, proteoglycans in cancer, signaling pathways regulating pluripotency of stem cells, rheumatoid arthritis, cyclic adenosine monophosphate (cAMP), interleukin 17 signaling pathway, circadian entrainment, and circadian rhythm, among others (Figure 6(a)).